Search
for
Sort by
Research 61–90 of 788
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- JAK Inhibitors for Treatment of Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Treatment of severe alopecia areata with baricitinib
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- 170 Forecasting Phase 3 Dose-Response for Abrocitinib, an Oral Janus Kinase 1 Selective Inhibitor, Using Investigator’s Global Assessment and Eczema Area and Severity Index
- Alopecia Areata
- Alopecia areata
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Under Development JAK Inhibitors for Dermatologic Diseases
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Keratin 6A promotes skin inflammation through JAK1-STAT3 activation in keratinocytes
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Whole-genome resequencing to investigate the genetic diversity and the molecular basis underlying key economic traits in indigenous sheep breeds adapted to hypoxic environments
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- A Review on the Use and Effectiveness of JAK Inhibitor in the Management of Lichen Planopilaris
- Alopecia Areata: Current Review
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Ruxolitinib for the treatment of severe alopecia areata